Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing laparoscopic ultrasound and fluorescence imaging with indocyanine green to map bile ducts during difficult laparoscopic gallbladder removal

Official title: Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy. Multicenter Comparative Study

Run by Consorci Sanitari Integral · NCT07400237 · Data updated 2026-11-12

This will try two imaging methods—laparoscopic ultrasound and fluorescence cholangiography with indocyanine green—in adults having technically difficult laparoscopic gallbladder removal to see which shows the bile duct anatomy best.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment62 (estimated)
SponsorConsorci Sanitari Integral
Academic / other
Locations1 site (Sant Joan Despí, Barcelona)
StatusRecruiting
StartedApril 1, 2025
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedFebruary 10, 2026
Trial IDNCT07400237 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) scheduled for laparoscopic cholecystectomy who are expected to have technical difficulty (for example acute cholecystitis, prior upper abdominal surgery, previous biliary interventions, or BMI ≥30) and who can give informed consent are ideal candidates.

Probably not a fit

People with known allergy to ICG or iodine, pregnancy or breastfeeding, high risk of common bile duct stones, thyroid disease, suspected gallbladder cancer, ASA class IV–V, advanced chronic kidney disease, or those planned for open cholecystectomy are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, prospective interventional study in which each participant will receive both laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG) during the same operation to allow direct within-patient comparison. LUS is performed first, followed by ICG fluorescence imaging prior to dissection of Calot's triangle using a standardized sequence. The primary endpoint is successful identification of the critical junction; secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, and intra- and postoperative complications. The trial focuses on cases anticipated to be technically difficult, such as acute cholecystitis, prior upper abdominal surgery, prior biliary disease, or obesity.

Why it matters

Potential benefit: If successful, better intraoperative imaging could lower the risk of bile duct injury and improve safety during difficult gallbladder operations.

How similar studies have gone: Both laparoscopic ultrasound and ICG fluorescence have been used successfully to visualize biliary anatomy in prior series, but direct head-to-head comparisons in technically challenging cases are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years.
2. Written informed consent provided.
3. Indication for laparoscopic cholecystectomy with anticipated technical difficulty due to one or more of the following:

   * Acute cholecystitis.
   * Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography.
   * Prior upper abdominal surgery.
   * Obesity (Body Mass Index ≥ 30 kg/m²).

Exclusion Criteria:

1. Known allergy to ICG or iodine.
2. Pregnancy or breastfeeding.
3. High risk of choledocholithiasis (ESGE guidelines).
4. Thyroid disease.
5. Suspected gallbladder malignancy.
6. ASA class IV-V.
7. Chronic kidney disease stage \> IIIb.
8. Planned open cholecystectomy.

Where it's running

  • Complex Hospitalari Universitari Moisès Broggi, Consorci Sanitari Integral
    Sant Joan Despí, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.